Polyhydroxy Patents (Class 514/669)
  • Patent number: 5863563
    Abstract: Methods and compositions for the treatment of the symptoms of a patient who has a pulmonary condition associated with an inhibition of surfactant secretion by type II alveolar cells are described. The method of treatment involves causing a patient to inhale an amount of a pH-raising buffer effective to raise the pH of the aqueous fluid in the microenvironment of the type II alveolar cell lumenal surface, thereby inducing an increase in the rate of surfactant secretion by type II alveolar cells.
    Type: Grant
    Filed: October 20, 1994
    Date of Patent: January 26, 1999
    Assignee: AlphaGene Inc.
    Inventor: George Scheele
  • Patent number: 5801202
    Abstract: Disclosed is an amine derivative represented by the following formula (1) or an acid addition salt thereof: ##STR1## wherein R.sup.1 represents a group ##STR2## a cyclopentyl group, cyclohexyl group, or a cycloheptyl group, R.sup.2 is a hydrogen atom or C1-C3 alkyl group which may be substituted by one or more hydroxyl groups, m is an integer falling in the range from 3 to 5 inclusive, and n is an integer falling in the range from 9 to 11 inclusive. Also, intermediates useful in the manufacture of the amine derivative (1), compositions for external application to the skin containing the amine derivative, and keratinization improvers containing the amine derivative as an active component are described. The compound (1) has excellent keratinization improving action, pigmentation preventing action, etc.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: September 1, 1998
    Assignee: Kao Coproration
    Inventors: Taketoshi Fujimori, Hiroshi Kusuoku, Akira Yamamuro, Yukihiro Yada, Kazuhiko Higuchi, Genji Imokawa, Naoki Kondo, Yoshinori Masukawa, Hajime Tokuda, Hisashi Tsujimura
  • Patent number: 5801181
    Abstract: Therapeutic compounds have the formula:(X)j--(core moiety),J being an integer from one to three, the core moiety having at least one, five- to seven-membered ring and X being a racemic mixture, R or S enantiomer, slovate, hydrate, or salt of: ##STR1## *C is a chiral carbon atom, n is an integer from one to four (preferably from one to three), one or more carbon atoms of (CH.sub.2).sub.n may be substituted by a keto or hydroxy group, and m is an integer from one to fourteen. Independently, R.sub.1 and R.sub.2 may be a hydrogen, a straight or branched chain alkane or alkene of up to twelve carbon atoms in length, or --(CH.sub.2).sub.w R.sub.5, w being an integer from two to fourteen and R.sub.5 being a mono-, di- or tri-substituted or unsubstituted aryl group, substituents on R.sub.5 being hydroxy, chloro, fluoro, bromo, or C.sub.1-6 alkoxy. Or jointly, R.sub.1 and R.sub.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 1, 1998
    Assignee: Cell Therapeutics, Inc.
    Inventors: John Michnick, Gail E. Underiner, J. Peter Klein, Glenn C. Rice
  • Patent number: 5753701
    Abstract: The present invention relates to N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters, and their use as agents for water disinfection and as mild oxidizing agents for the radiolabeling of oxidation-sensitive biomolecules.
    Type: Grant
    Filed: October 25, 1996
    Date of Patent: May 19, 1998
    Assignee: University of Kentucky
    Inventors: Anwar A. Hussain, Bassam Tashtoush, Lewis W. Dittert
  • Patent number: 5723497
    Abstract: The present invention relates to an amine derivative represented by the following general formula (I) or (II): ##STR1## wherein R.sup.1 means a heteroatom-containing C.sub.1 -C.sub.40 hydrocarbon group which may have a ring structure, or the like; R.sup.2 -R.sup.5 each denote a C.sub.1 -C.sub.20 hydrocarbon group, hydrogen or the like; A.sup.1 represents ##STR2## or R.sup.15 --Z--.sup.16 --(CH.sub.2).sub.n --; B.sup.1 stands for hydrogen, a C.sub.1 -C.sub.10 hydrocarbon group, nitrogen or the like; C.sup.1 denotes hydrogen, a C.sub.1 -C.sub.10 hydrocarbon group, nitrogen, alcohol residue, phosphoric acid residue or the like; a dermatologic preparation containing the same; and a process for producing the amine derivative. This amine derivative has excellent effects of smoothing or removing wrinkles and improving keratinization.
    Type: Grant
    Filed: September 18, 1995
    Date of Patent: March 3, 1998
    Assignee: Kao Corporation
    Inventors: Yukihiro Ohashi, Yukihiro Yada, Yoshinori Takema, Taketoshi Fujimori, Akira Kawamata, Hiroyuki Ohsu, Kazuhiko Higuchi, Genji Imokawa, Hiroshi Kusuoku, Ayumi Ogawa, Tsutomu Fujimura
  • Patent number: 5681864
    Abstract: A composition for external skin care comprising an amine derivative represented by the following formula (1), ##STR1## wherein R.sup.1 is a linear, branched, or cyclic saturated or unsaturated hydrocarbon group having 4-40 carbon atoms, and R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are individually a hydrogen atom or a hydrocarbon group having 1-10 carbon atoms, which may be substituted or unsubstituted by 1 or more hydroxy groups; or an acid addition salt thereof, in an amount from 0.0001 to less than 0.1% by weight; and a method of curing wrinkles and keratinization of the skin characterized by applying said amine derivative or its salt to the skin.
    Type: Grant
    Filed: December 6, 1996
    Date of Patent: October 28, 1997
    Assignee: Kao Corporation
    Inventors: Yukihiro Ohashi, Taketoshi Fujimori, Minoru Nagai, Akira Kawamata, Yukihiro Yada, Kazuhiko Higuchi, Genji Imokawa, Yoshinori Takema, Yukiko Sakaino, Ayumi Ogawa, Tsutomu Fujimura
  • Patent number: 5681859
    Abstract: A non-toxic, environmentally safe and easily employable insecticide and insect repellant is achieved by providing an aqueous composition incorporating ethanolamine based compounds, either independently or in combination with the ethanolamine based compounds being selected from both simple compounds and conjugated compounds. In one preferred embodiment, a highly effective composition is attained for safe, effective, direct topical application to humans and animals by employing between about 10% and 70% by volume of the entire composition of the ethanolamine-based compound. In alternate preferred embodiments, the insecticide is formulated for application to plants, trees, crops, and other vegetation to provide a composition which effectively controls bothersome insects, while being completely safe and non-injurious to the plant, tree, or crop, as well as to the flowers or fruit thereof.
    Type: Grant
    Filed: September 6, 1995
    Date of Patent: October 28, 1997
    Assignee: Lynn Sue James
    Inventors: Lynn Sue James, Michael A. Siedman
  • Patent number: 5677341
    Abstract: An acidic emulsion comprising a lipoid dispersed in an aqueous phase, a cationic sphingolipid, and a stabilizing amount of non-ionic surfactant and cholesterol is provided, along with the method of administering the emulsion.
    Type: Grant
    Filed: July 16, 1996
    Date of Patent: October 14, 1997
    Assignees: Pharmacia & Upjohn Aktiebolag, Eli Lilly and Company
    Inventor: Robert T. Lyons
  • Patent number: 5614558
    Abstract: A non-toxic, environmentally safe and easily employable insecticide and insect repellant is achieved by providing an aqueous composition incorporating ethanolamine based compounds, either independently or in combination with the ethanolamine based compounds being selected from both simple compounds and conjugated compounds. In one preferred embodiment, a highly effective composition is attained for safe, effective, direct topical application to humans and animals by employing between about 10% and 70% by volume of the entire composition of the ethanolamine-based compound. In alternate preferred embodiments, the insecticide is formulated for application to plants, trees, crops, and other vegetation to provide a composition which effectively controls bothersome insects, while being completely safe and non-injurious to the plant, tree, or crop, as well as to the flowers or fruit thereof.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: March 25, 1997
    Assignee: Lynn Sue James
    Inventors: Lynn S. James, Michael A. Siedman
  • Patent number: 5583160
    Abstract: N-methylated sphingosine used to induce apoptosis.
    Type: Grant
    Filed: December 14, 1994
    Date of Patent: December 10, 1996
    Assignee: The Biomembrane Institute
    Inventors: Yasuyuki Igarashi, Sen-Itiroh Hakomori
  • Patent number: 5552445
    Abstract: A composition for external skin care comprising an amine derivative represented by the following formula (1), ##STR1## wherein R.sup.1 is a linear, branched, or cyclic saturated or unsaturated hydrocarbon group having 4-40 carbon atoms, and R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are individually a hydrogen atom or a hydrocarbon group having 1-10 carbon atoms, which may be substituted or unsubstituted by 1 or more hydroxy groups; or an acid addition salt thereof, in an amount from 0.0001 to less than 0.1% by weight; and a method of curing wrinkles and keratinization of the skin characterized by applying said amine derivative or its salt to the skin.
    Type: Grant
    Filed: March 23, 1994
    Date of Patent: September 3, 1996
    Assignee: Kao Corporation
    Inventors: Yukihiro Ohashi, Taketoshi Fujimori, Minoru Nagai, Akira Kawamata, Yukihiro Yada, Kazuhiko Higuchi, Genji Imokawa, Yoshinori Takema, Yukiko Sakaino, Ayumi Ogawa, Tsutomu Fujimura
  • Patent number: 5534553
    Abstract: This invention relates to the use of fatty amino alcohols or derivatives thereof as drugs for the consequences of drug dependency.
    Type: Grant
    Filed: March 7, 1994
    Date of Patent: July 9, 1996
    Inventor: Wilhelm Hoerrmann
  • Patent number: 5470878
    Abstract: Therapeutic compounds have the formula:(X)j-(non-cyclic core moiety),j being an integer from one to three, the core moiety is non-cyclic and X is a racemic mixture, R or S enantiomer, solvate, hydrate, or salt of: ##STR1## *C is a chiral carbon atom, n is an integer from one to four (preferably from one to three), one or more carbon atoms of (CH.sub.2).sub.n may be substituted by a keto or hydroxy group, and m is an integer from one to fourteen. Independently, R.sub.1 and R.sub.2 may be a hydrogen, a straight or branched chain alkane or alkene of up to twelve carbon atoms in length, or --(CH.sub.2).sub.w R.sub.5, w being an integer from two to fourteen and R.sub.5 being a mono-, di- or tri-substituted or unsubstituted aryl group, substituents on R.sub.5 being hydroxy, chloro, fluoro, bromo, or C.sub.1-6 alkoxy. Or jointly, R.sub.1 and R.sub.2 form a substituted or unsubstituted, saturated or unsaturated heterocyclic group having from four to eight carbon atoms, N being a hetero atom. R.sub.
    Type: Grant
    Filed: December 8, 1993
    Date of Patent: November 28, 1995
    Assignee: Cell Therapeutics, Inc.
    Inventors: John Michnick, Gail E. Underiner, J. Peter Klein, Glenn C. Rice
  • Patent number: 5436241
    Abstract: The composition contains: an antiinflammatory effective amount of piroxicam; an amount of tetrahydroxypropylethylenediamine sufficient to solubilize the piroxicam in the composition; an amount of C.sub.2 -C.sub.6 alkylene glycol, or mixture thereof, sufficient to detackify the composition and provide humectancy; about 0.2% to about 2% carbomer; about 30% to about 60% C.sub.2 -C.sub.4 alkanol; and water qs to 100%. Hydroxypropylcellulose can be added to the composition.
    Type: Grant
    Filed: January 14, 1994
    Date of Patent: July 25, 1995
    Assignee: Bristol-Myers Squibb Company
    Inventors: Chung Shin, Luc Bossuyt
  • Patent number: 5278178
    Abstract: This invention relates to synergistic antimicrobial and biocidal compositions comprising 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one and one or more commercial biocides for more effective, and broader control of microorganisms in various industrial systems.
    Type: Grant
    Filed: April 29, 1993
    Date of Patent: January 11, 1994
    Assignee: Rohm and Haas Company
    Inventor: Jemin C. Hsu
  • Patent number: 5246913
    Abstract: This invention relates to synergistic antimicrobial and biocidal compositions comprising 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one and one or more commercial biocides for more effective, and broader control of microorganisms in various industrial systems.
    Type: Grant
    Filed: October 30, 1992
    Date of Patent: September 21, 1993
    Assignee: Rohm and Haas Company
    Inventor: Jemin C. Hsu
  • Patent number: 5229422
    Abstract: An extemporaneous kit of pharmaceutical substance-containing fat emulsion which consists of a fat emulsion and (a) a pharmaceutical substance composition containing pharmaceutical substance and at least one solvent selected from the group consisting of water, liquid polyalkylene glycols, liquid alkylethanolamines, and liquid polyhydric alcohols, or (b) a pharmaceutical substance composition containing pharmaceutical substance and saccharides and/or 30 amino acids as an excipient, and a process for preparation of a pharmaceutical substance-containing fat emulsion therefrom.
    Type: Grant
    Filed: June 13, 1991
    Date of Patent: July 20, 1993
    Assignee: Teijin Limited
    Inventors: Ken Takahashi, Yuji Makino, Yoshiki Suzuki, Tatsuyuki Naruchi
  • Patent number: 5223515
    Abstract: An injectable solution of a compound useful as an anti-ulcer agent of the formula; ##STR1## wherein R.sup.1 represents hydrogen, methoxy or trifluoromethyl group; R.sup.2 and R.sup.3, being the same as or different from each other, represent hydrogen or methyl group; and R.sup.4 represents a fluorinated C.sub.2 to C.sub.5 lower alkyl group, is provided by dissolving the compound in at least one of ethanol, propylene glycol and polyethylene glycol; or by dissolving the freeze-dried material of an alkaline aqueous solution of the compound in a mixture of an acidic substance and at least one of the above solvents.
    Type: Grant
    Filed: August 4, 1992
    Date of Patent: June 29, 1993
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Yasushi Mikura, Akihiro Nagai, Hisayoshi Shimizu
  • Patent number: 5023008
    Abstract: Novel nonionic antimicrobial amine glycidol compounds which may be used in cleaning compositions with anionics, nonionics or cationic surfactants as cleaning agents or a preservative in water-based functional fluids or surface coating compositions are represented by the formula: ##STR1## wherein R represents an alkyl group having from about 8 to about 18 carbon atoms and mixtures thereof,Y represents H, ##STR2## or R', and mixtures thereof; R' represents an alkyl group, the sum total of carbon atoms in R+R' being from about 8 to about 18;n is from about 1 to about 6; andm+n are from about 2 to about 12;wherein the molar ratio of amine glycidol compound to surfactant is from about 10:1 to about 1:10.
    Type: Grant
    Filed: November 17, 1989
    Date of Patent: June 11, 1991
    Assignee: Olin Corporation
    Inventors: Michael Scardera, Frank R. Grosser
  • Patent number: 4985245
    Abstract: A medical composition which contains a tissue Plasminogen Activator (tPA) in combination with meglumine or a salt thereof.
    Type: Grant
    Filed: November 3, 1989
    Date of Patent: January 15, 1991
    Assignee: Eisai Co., Ltd.
    Inventors: Fumio Kakimoto, Naoki Asakawa, Yasuo Ishibashi, Yasuo Miyake
  • Patent number: 4952567
    Abstract: A process which comprises administering an antagonist of protein kinase C and/or the insulin receptor tyrosine kinase to a mammal in an amount therapeutically effective to inhibit lipogenesis in the mammal.
    Type: Grant
    Filed: July 8, 1988
    Date of Patent: August 28, 1990
    Assignee: City of Hope
    Inventors: Pierre DeMeyts, Jean Smal, Yoko Fujita-Yamaguchi
  • Patent number: 4937269
    Abstract: Quadrol and homologs and analogs thereof have been found to stimulate macrophage activity in warm blooded animals. As a consequence, these compounds may be used to combat bacterial infection, remove degenerated tissue, and promote new tissue growth. Quadrol or a homolog or analog thereof may be applied topically, e.g., as the active agent in a wound dressing. The active compounds may be represented by the formula (I) ##STR1## wherein R.sub.1 and R.sub.2 are substituted alkyl (C.sub.2 -C.sub.6) in which the substituents include one or more hydroxyl groups attached to carbon atoms other than the alpha carbon atom, R.sub.3 and R.sub.4 are alkyl or substituted alkyl (C.sub.1 -C.sub.6), and n=2 to about 6. Preferably R.sub.1 through R.sub.4 are the same and are 2-hydroxyalkyl.
    Type: Grant
    Filed: October 14, 1988
    Date of Patent: June 26, 1990
    Assignee: University of Akron
    Inventors: Daniel J. Smith, Sanjay R. Patel, Edwin C. Rowland
  • Patent number: 4923887
    Abstract: Antimicrobially active liquid composition formulation which comprises 1,2-benzisothiazolin-3-one and at least one amine-oxyethylate of the formula ##STR1## wherein R is alkyl or alkenyl each having 2 to 22 carbon atoms and the sum of m and n is a number from 2 to 30 is used as an improved biocide to preserve and protect aqueous solutions from infestation with micro-organisms.
    Type: Grant
    Filed: August 25, 1988
    Date of Patent: May 8, 1990
    Assignee: Cassella Aktiengesellschaft
    Inventors: Wolfgang Bauer, Hans-Walter Bucking, Karl-Heinz Wallhausser
  • Patent number: 4829083
    Abstract: The invention relates to the stabilization of mercury-containing preservatives in liquid or gel-form ophthalmic medicaments. This stabilization against chemical decomposition after the preservative has become deposited on the inner walls of the plastics containers is achieved by adding to the formulation 2-amino-2-hydroxymethyl-1,3-propanediol or a homologue thereof having up to 10 carbon atoms.
    Type: Grant
    Filed: April 14, 1987
    Date of Patent: May 9, 1989
    Assignee: Dispersa AG
    Inventor: Johann Doulakas
  • Patent number: 4778825
    Abstract: Quadrol has been found to stimulate macrophage activity in warm blooded animals. As a consequence, Quadrol may be used to combat bacterial infection, remove degenerated tissue, and promote new tissue growth. Quadrol may be applied topically, e.g., as the active agent in a wound dressing.
    Type: Grant
    Filed: August 29, 1986
    Date of Patent: October 18, 1988
    Assignee: The University of Akron
    Inventors: Daniel J. Smith, Sanjay R. Patel, Edwin C. Rowland
  • Patent number: 4655815
    Abstract: The present invention is directed to a synergistic antimicrobial admixture comprising 2-bromo-2-bromomethylglutaronitrile and a formaldehyde donor.
    Type: Grant
    Filed: March 27, 1985
    Date of Patent: April 7, 1987
    Assignee: Calgon Corporation
    Inventor: John A. Jakubowski